CASP8 and neural tube defect: After Bonferroni correction, all of the sites demonstrated significant hypomethylation in NTD cases with a β difference ranging between 8.8% and 26.3%, reaffirming hypomethylated status in the promoter region of CASP8 in NTD cases.